We worked with a billion-dollar biopharmaceutical company for nearly a decade, providing Sarbanes-Oxley 404 compliance programs. During this time the company experienced explosive growth through international acquisitions. They sought our ongoing support to ensure they could integrate the new entities while remaining SOX compliant.
We added the company’s new European operations to the engagement scope and developed procedures to identify, document and assess management’s internal control over financial reporting. We also helped the client plan for a software upgrade that would maintain the control environment.
We provided this client with a range of ongoing compliance services to help them integrate new international entities while remaining compliant with SOX and other requirements. We validated management’s internal control over financial reporting and ensured that internal controls were documented and operating in accordance with the requirements of their Big Four auditor.